| M - Musculo-Skeletal System | | |
|
| M09 - Other Drugs for Disorders Of The Musculo-Skeletal System | | |
|
| M09A - Other Drugs for Disorders Of The Musculo-Skeletal System | This group comprises preparations used in disorders of the musculo-skeletal system, which cannot be classified in the preceding groups.
|
|
| M09AX - Other Drugs for Disorders Of The Musculo-Skeletal System | Hyaluronic acid injection for intraarticular administration (e.g. 2.5 mg/ampoule) used in the treatment of arthritis is classified in this group. Hyaluronic acid injection used during surgical procedures on the eye (e.g. 4-20 mg/ampoule) is classified in S01K.
Mexiletine indicated for myotonic disorders is classified in C01BB.
| The DDD for hyaluronic acid is based on intraarticular treatment of arthritis. The DDD is assigned according to daily dose even if the product is given as weekly injections.
|
|
|
